Azienda Unita' Locale Socio Sanitaria N. 2 Marca Trevigiana

At Azienda Unita' Locale Socio Sanitaria N. 2 Marca Trevigiana in Treviso, a large share of the clinical research focuses on neoplasms and blood cancers, including ovarian cancer, non-small cell lung cancer, endometrial cancer, cervical cancer, lymphoma, and acute leukemia. These studies are mainly designed to test new treatment options, improve disease control, and evaluate whether novel combinations can extend survival or reduce recurrence.

• Studies in advanced and recurrent ovarian cancer are exploring new maintenance and combination strategies to improve disease control.
• Research in non-small cell lung cancer is examining targeted and immunotherapy-based approaches for both early and advanced disease.
• Trials in hematologic malignancies such as mantle cell lymphoma, follicular lymphoma, and acute myeloid leukemia are evaluating more effective treatment pathways.

Overall, this is a strong oncology program with a clear emphasis on personalized cancer care and better outcomes for difficult-to-treat diseases.

The site also conducts important work in cardiovascular diseases and vascular disease, with studies centered on heart failure, venous thromboembolism, pulmonary embolism, pericarditis, and suspected arterial disease. The aim is to improve prevention, reduce complications, and refine treatment choices for patients with common and high-risk circulatory disorders.

• Trials in heart failure are assessing whether new therapies can better control symptoms and lower the risk of hospitalization.
• Research on venous thromboembolism and pulmonary embolism is focused on preventing recurrence and improving safety.
• Work on vascular disease includes better imaging approaches to support diagnosis and treatment planning.

These studies reflect a broad interest in both prevention and long-term management of cardiovascular conditions.

Another key research area at the hospital involves immune system diseases and immune system processes, including generalized myasthenia gravis, eosinophilic granulomatosis with polyangiitis, hypereosinophilic syndrome, chronic graft-versus-host disease, severe asthma, and juvenile idiopathic arthritis. These trials are intended to test new immune-modulating therapies, improve symptom control, and support better disease remission.

• Studies in generalized myasthenia gravis are evaluating treatments aimed at improving muscle strength and daily function.
• Research in eosinophilic and inflammatory disorders is examining options to better control persistent immune activity.
• Trials in rheumatologic disease and chronic graft-versus-host disease are focused on reducing disease burden and improving quality of life.

This field shows a strong interest in conditions where the immune system plays a central role in disease progression.

Clinical research also covers respiratory tract diseases, digestive system diseases, and nutritional and metabolic diseases. The main conditions studied include chronic lung disease, inflammatory bowel disease, and type 2 diabetes mellitus, with additional work in metabolic heart failure and obesity-related disease. The purpose of these studies is to improve treatment durability, symptom control, and metabolic outcomes in everyday clinical practice.

• In inflammatory bowel disease, research is looking at ways to improve the effectiveness of established therapies over time.
• Studies in chronic lung disease are evaluating better care for patients with significant breathing problems.
• Research in type 2 diabetes mellitus is comparing treatment strategies to help patients reach safer glucose targets.

This mix of studies highlights the site’s interest in chronic diseases that require long-term, practical management.

A substantial portion of the trial portfolio is devoted to female urogenital diseases and pregnancy complications, especially ovarian cancer, endometrial cancer, cervical cancer, and vulvar cancer. These studies are designed to test new cancer therapies, improve post-surgical outcomes, and reduce the chance of disease returning after treatment.

• Research in ovarian cancer includes studies for newly diagnosed, recurrent, and treatment-resistant disease.
• Trials in endometrial cancer and cervical cancer are exploring targeted and immune-based approaches.
• Work in vulvar cancer is evaluating whether modern combination treatments can improve responses.

This area shows a strong commitment to advancing care for gynecologic cancers across different stages of disease.

The remaining studies include work in musculoskeletal diseases, nervous system diseases, and analytical, diagnostic and therapeutic techniques and equipment. Research topics include polyarticular-course juvenile idiopathic arthritis, imaging for vascular disease, and diagnostic support for complex clinical conditions. The main goal is to improve diagnosis, monitor disease more accurately, and support more effective treatment decisions.

• Studies in juvenile idiopathic arthritis are testing better ways to control joint inflammation in children and adolescents.
• Diagnostic research includes advanced magnetic resonance angiography to improve detection of vascular abnormalities.
• Neurologic and neuromuscular work is focused on conditions that affect strength, movement, and daily functioning.

At this site, these studies complement the broader disease-focused portfolio by supporting earlier and more precise care.